Hence, GLRX3 overexpression may be involved in the modulation of EBV latent infection in NPC cells, thus contributing to tumorigenesis and progression by reduced immunogenicity of NPC cells. This evidence concerns the gene GLRX3 and disease arising from reactivation of latent virus.